Previous 10 | Next 10 |
Omeros (NASDAQ: OMER ) : Q2 GAAP EPS of -$0.61 misses by $0.02 . More news on: Omeros Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
Omeros Corporation (Nasdaq: OMER) (“Omeros”) today announced that it has commenced concurrent underwritten public offerings of $125,000,000 of shares of its common stock (the “Shares”) and $200,000,000 aggregate principal amount of convertible senior notes due 2026...
Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of th...
Gainers: Seres Therapeutics (NASDAQ: MCRB ) +356% . More news on: Seres Therapeutics, Inc., Xtant Medical Holdings, Inc., BiomX Inc., Stocks on the move, , Read more ...
Seres Therapeutics (NASDAQ: MCRB ) +266% on success of lead drug in C. diff study. More news on: Seres Therapeutics, Inc., Trevena, Inc., Hoth Therapeutics, Inc., Stocks on the move, , Read more ...
Omeros (NASDAQ: OMER ) jumps 45% premarket on increased volume in reaction to positive results from a compassionate-use study evaluating narsoplimab in severely ill COVID-19 patients with acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. More news...
-- All six patients, requiring mechanical ventilation prior to treatment, recovered, survived and were discharged from the hospital -- Narsoplimab treatment was associated with rapid and sustained improvement across all assessed markers of endothelial/cellular damage and/or inflammatio...
I have been singing the praises of Omeros since my first Omeros ( OMER ) article , "Omeros: Beauty and the Beast", back in March of 2018. At the time I noted Omeros' great attractions: its beauty, against an ominous background: the ever lurking beast. In the intervening time it seems that n...
Many investors have made tons of money by investing in small-cap biotech stocks, especially those that are still relatively obscure. One potential investment candidate that's slipped under the radar due to the coronavirus pandemic is Omeros Corporation (NASDAQ: OMER) . A biotech company that ...
Without education, we are in a horrible and deadly danger of taking educated people seriously. "― G.K. Chesterton Today, we revisit a name we have covered often over the past two years. The company has been maddening for investors as the shares trade at the same level as a year ago...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 09:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
$118.1 million, or 55%, of outstanding convertible notes due in 2026 repurchased at approximately 75% of notional value, resulting in $51 million in total debt extinguishment Repurchase funded from new $67 million secured four-year term loan maturing in June 2028 together with $21 million...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 419.5% to $0.24 on volume of 2,920,436,648 shares Greenwave Technology Solutions Inc. (GWAV) rose 147.7% to $0.1481 on volume of 1,864,631,229 shares Faraday Future Intelligent Electric Inc. (FF...